| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Heart and Circulatory Physiology, Vol 257, Issue 4 1088-H1095, Copyright © 1989 by American Physiological Society
ARTICLES |
F. D. Romano, S. G. MacDonald and J. G. Dobson Jr
Department of Physiology, University of Massachusetts Medical School, Worcester 01655.
The effects of adenosine analogues on beta-adrenergic receptor and receptor-independent elicited increases in adenylate cyclase activity were investigated using membranes obtained from primary cultures of adult rat ventricular myocytes. Phenylisopropyladenosine, an A1-receptor agonist, at concentrations of 0.1, 1.0, and 10 microM, maximally inhibited isoproterenol-stimulated adenylate cyclase activity by 35, 55, and 41%, respectively. The inhibition by phenylisopropyladenosine was antagonized by 10 microM theophylline. One micromolar phenylisopropyladenosine was much less effective at attenuating forskolin-stimulated activity, such that the maximum inhibition was 26%. Phenylisopropyladenosine had no effect on adenylate cyclase stimulation by 5'-guanylylimidodiphosphate. Phenylaminoadenosine, an A2 agonist, at 10 microM or greater stimulated adenylate cyclase activity. This effect was not significantly inhibited by theophylline or 0.1 microM 1,3-dipropyl-8-cyclopentylxanthine (DPCPX), which antagonized phenylisopropyladenosine inhibition of isoproterenol-stimulated adenylate cyclase activity. Additionally, N-ethylcarboxamidoadenosine, a nonselective adenosine-receptor agonist, had no effect on adenylate cyclase activity in the absence of DPCPX but stimulated adenylate cyclase activity in the presence of DPCPX. These results indicate that both A1 and A2 receptors exist on the ventricular myocyte sarcolemma. More importantly, the findings suggest that adenosine inhibition of catecholamine-stimulated adenylate cyclase activity is primarily due to an alteration in beta-adrenergic receptor-mediated transduction and perhaps in part by a direct inhibition of the catalytic component.
This article has been cited by other articles:
|
|
 |
|
  K. Miyazaki, S. Komatsu, M. Ikebe, R. A. Fenton, and J. G. Dobson Jr. Protein kinase C{epsilon} and the antiadrenergic action of adenosine in rat ventricular myocytes Am J Physiol Heart Circ Physiol, October 1, 2004; 287(4): H1721 - H1729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. Headrick, B. Hack, and K. J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Dobson Jr., L. G. Shea, and R. A. Fenton {beta}-Adrenergic and antiadrenergic modulation of cardiac adenylyl cyclase is influenced by phosphorylation Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1471 - H1478. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Liu and P. A. Hofmann Antiadrenergic effects of adenosine A1 receptor-mediated protein phosphatase 2a activation in the heart Am J Physiol Heart Circ Physiol, October 1, 2002; 283(4): H1314 - H1321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Lester and P. A. Hofmann Role for PKC in the adenosine-induced decrease in shortening velocity of rat ventricular myocytes Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H2685 - H2693. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. S. Monahan, D. R. Sawmiller, R. A. Fenton, and J. G. Dobson Jr. Adenosine A2a-receptor activation increases contractility in isolated perfused hearts Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1472 - H1481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. R. Norton, A. J. Woodiwiss, R. J. McGinn, M. Lorbar, E. S. Chung, T. W. Honeyman, R. A. Fenton, J. G. Dobson Jr., and T. E. Meyer Adenosine A1 receptor-mediated antiadrenergic effects are modulated by A2a receptor activation in rat heart Am J Physiol Heart Circ Physiol, February 1, 1999; 276(2): H341 - H349. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. B. Marala and S. J. Mustafa Immunological Characterization of Adenosine A2A Receptors in Human and Porcine Cardiovascular Tissues J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 1051 - 1057. [Abstract] [Full Text]
|
|
|
|
|
|
D. R. Sawmiller, R. A. Fenton, and J. G. Dobson Jr. Myocardial adenosine A1-receptor sensitivity during juvenile and adult stages of maturation Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H627 - H635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Feoktistov and I. Biaggioni Adenosine A2B Receptors Pharmacol. Rev., December 1, 1997; 49(4): 381 - 402. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. L. Kilpatrick, P. Narayan, R. M. Mentzer Jr., and R. D. Lasley Cardiac myocyte adenosine A2a receptor activation fails to alter cAMP or contractility: role of receptor localization Am J Physiol Heart Circ Physiol, March 1, 2002; 282(3): H1035 - H1040. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
